ImmunityBio
IBRX
IBRX
191 hedge funds and large institutions have $390M invested in ImmunityBio in 2024 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 61 increasing their positions, 46 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.93% less ownership
Funds ownership: 9.85% → 8.91% (-0.93%)
31% less call options, than puts
Call options by funds: $24.8M | Put options by funds: $35.9M
Holders
191
Holding in Top 10
2
Calls
$24.8M
Puts
$35.9M
Top Buyers
| 1 | +$8.9M | |
| 2 | +$8.82M | |
| 3 | +$6.62M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$5.61M |
| 5 |
AWM
Accurate Wealth Management
Wesley Chapel,
Florida
|
+$3.56M |
Top Sellers
| 1 | -$39.9M | |
| 2 | -$7.62M | |
| 3 | -$6.44M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$5.65M |
| 5 |
Rafferty Asset Management
New York
|
-$5.53M |